Hypertrophic obstructive cardiomyopathy is a disease of relatively recent recognition which is known in North America as idiopathic hypertrophic subaortic stenosis The details of the disease have been reported previously (Braunwald et al., I960, I964; Goodwin et al., I960; Wigle, Heimbecker, and Gunton, I962; Goodwin, i967; Cohen et al., I964) .
It is the purpose of this paper to report our experience of the long-term follow-up of patients with hypertrophic obstructive cardiomyopathy with reference to symptoms and the occurrence of sudden death, and with comments on treatment. We have attempted
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to relate the symptoms and signs of the patients, together with their more objective features, when initially seen, to the subsequent course of the disease.
The patients (Table I) This study covers (82%) and characteristic phonocardiographic responses to pharmacological stimulation (Goodwin et al., I964) made the diagnosis certain. In all other cases the diagnosis was confirmed by haemodynamic and angiocardiographic studies (Cohen et al., I964; Simon, Ross, and Gault, I967) . In IO patients (I2%) there was neither a resting gradient across the outflow tract of the left ventricle nor a gradient after provocation, but in these the combination of the clinical picture and unmistakable angiographic appearances also made the diagnosis certain. The remaining 70 patients had typical haemodynamic and angiographic abnormalities.
Further confirmation was obtained in those who came to operation or necropsy.
Forty-five (52%) were male and 40 (48%) were female. The youngest included in the series was 21 years old; the oldest was 55 years at the time of inclusion. The longest follow-up was I2 years, the shortest 6 months. Twenty-one patients (25 %) were followed for more than 5 years, i5 (i8 %) for less than 2 years. The average follow-up was 4-0 years. Twenty-three patients (27%) were asymptomatic on ordinary activity when first seen. Forty-five patients (53%) had had symptoms for less than 5 years when first seen, 22 (26%) from 6 to IO years, and 13 (i5%) from ii to i5 years.
Only 5 had had cardiac symptoms for more than I5 years when first seen. The average duration of symptoms or of recognition of a murmur without symptoms was 8-i years.
There were 12 deaths (14%), 6 postoperative, 6 sudden; 2 died from infective endocarditis (one due to a ruptured cerebral mycotic aneurysm), and one was due to an unrelated neurological condition.
Presentation and progress according to symptoms (Table 2) The symptoms have been graded according to the New York Heart Association functional Twenty-three patients (27%) were in Class I when seen initially. Of these, 5 were familial and i8 sporadic. Two ofthe sporadic patients have died suddenly; the remaining 2 I patients have stayedunchanged during the follow-up period. The average age at diagnosis in this group was I3'9 years, and the average age at inclusion into the series was 2I 6 years, making an almost 8-year average interval between the initial detection of a murmur and referral, during which time no symptoms developed. The mode of discovery was either fortuitous detection of a murmur or examination because of a family history suggestive of heart disease.
Fifty-one of the 85 patients (60%) presented with Class II symptoms. Seventeen (33%) remained the same, I6 (3I%) improved, and 9 (i8%) deteriorated during the course of followup. Nine patients died, 6 after surgical treatment, 2 suddenly and unexpectedly, and i from infective endocarditis. Both the average age of detection (27-6 years) and of inclusion into the series (35-8 years) was higher than in the preceding group.
Ten patients (iii%) presented with Class III symptoms. Five (50%) improved, 3 (30%) deteriorated, i (io%) remained the same, and i (io%) died. The average age of onset in these was 25-9 years, which is similar to those with Class II symptoms. However, the average age at inclusion into the series (29-3 years) was less than in Class II, perhaps indicating a more rapidly progressive form of the disease in this group.
One patient, aged 34, presented initially in or initial symptoms had been noted in IO (46%) before their 20th birthday, a lower percentage than in the preceding group. The average duration when first seen was 5 7 years.
Symptoms (group C) There were I2 patients, the average age at onset being 30o0 years, greater than either group A or B. The mean duration of symptoms when first seen was 6-9 years. Nine (75%) originally presented with Class II symptoms and 3 (25%) with Class IV symptoms. Subsequent study has revealed a characteristic pattern of deterioration in which the rise in left atrial pressure may be followed by atrial fibrillation and embolism (Oakley, I97ia (io%) patients in group A, 6 patients (27%) in group B, and i patient (8%) in group C. Right axis deviation ( > +go) occurred in i patient in groups A and B and in 2 patients in group C.
Atrial enlargement Electrocardiographic evidence of left atrial hypertrophy, consisting of a 'P' wave duration in lead II of greater than O-Io mm, occurred significantly less often in group A (20%) than in either group B (50%) or group C (42%). The difference between groups B and C is not significant. Right atrial hypertrophy (a 'P' wave amplitude in lead II greater than 2-5 mm) was present in 2 patients. In both, a right ventricular outflow tract gradient was present.
Electrocardiographic evidence of left atrial hypertrophy was correlated positively with the average left ventricular end-diastolic pressure. Patients with left atrial hypertrophy had a mean LV end-diastolic pressure of 19 ± 5 mmHg, but in those without left atrial hypertrophy the average end-diastolic pressure was I3 ± 4 mmHg (P= <O oi).
Ventricular hypertrophy
The criteria used for the electrocardiographic diagnosis of left ventricular hypertrophy were as follows. Svj+Rv,,,6=35 mv; RaVL=ii mv; R1+S111=40 mv (Sokolow and Lyon, I949) .
In the series, 38 patients (52%) had one or more criteria for this diagnosis. Left ventricular hypertrophy occurred with similar frequency between the groups, and for this reason did not have a prognostic value. The electrocardiogram with the greatest voltage ( Fig. 3) (Braudo, Wigle, and Keith, I964), or to septal fibrosis (Wigle, I964) . Though many of our patients had a history of angina, in none of them was there a history of myocardial infarction, and we have found widely patent normal coronary arteries in 6 patients with hypertrophic obstructive cardiomyopathy who have undergone selective coronary arteriography.
Accelerated conduction
The established criteria for the diagnosis of the Wolff-Parkinson-White syndrome (Wolff, Parkinson, and White, 1930 ) is a PR interval of less than (Goodwin, 1970; Oakley, i97ib The fourth patient, a 49-year-old woman, presented a somewhat more encouraging picture. She was followed at Hammersmith Hospital for 6 lta wave, and pro-years, though a cardiac murmur was first heard at ex. Though their the age of i8 years. During the course of follow-up )f our patients, an she remained in Class II. More recently she was Ll occurred in 4 treated with propranolol. She had several episodes group C. Two of of fibrillation during which she deteriorated to ne had QRS pro-Class III. However, on reversion to sinus rhythm, supraventricular she returned to her usual status. In contrast to ilial.
the three men, the signs of outflow obstruction vailable for review continued to dominate her clinical picture. Her ed few significant electrocardiogram showed only borderline left arse of follow-up, atrial hypertrophy when in sinus rhythm.
ealed the developNevertheless, atrial fibrillation is usually a vaves, or widening sinister manifestation of increasing resistance to ley, I97ia; Good-ventricular filling and an indicator of an advanced stage of the disease. Subsequent experience revealed atrial fibrillation in I4 patients, all of whom deteriorated as a result of the loss of atrial 'drive' n in hvnertrnnhic (Goodwin, I970; Oakley, I97Ia) .
In Frank and it occurred in 8 E observed it in 4 7, 33, and 37 and 1 fibrillation was 3 established; the Haemodynamic data (Table 5) Left ventricular outflow tract obstruction The assessments of left ventricular gradients were available in 33 patients in group A, 22 patients in group B, and 9 in group C (Table 5 ). For uniformity, we have chosen the highest recorded basal gradient in each patient. The average gradient was 4I ± 37 mmHg for all patients (Fig. 5) .
In group A the average gradient was 36±31 mmHg, 8 patients having no resting gradient. Four of these developed gradients after provocation with isoprenaline, one developed a postectopic gradient consistently, and an additional patient developed a gradient of 75 mmHg after exercise. The remaining 2 were not subjected to provocative drugs or manoeuvres.
The average gradient in group B was 70±38 mmHg, being significantly greater than group A (P = o-ooi). There were 2 patients without gradients at rest. There was no difference between the patients in Classes II or III in this group. One patient developed a gradient of 65 mmHg with isoprenaline, and the other was not tested in this way. The lone patient in Class II had a gradient of I00 mmHg.
The average gradient in the 9 patients in group C was 43 ± 35 mmHg, which is not significantly higher than group A, but less than group B (P =oo8). In 3 patients (all initially with Class II symptoms) there was no resting gradient. Two of these developed gradients of 40 and 6o mmHg, respectively after provocation. The third patient developed no gradient despite provocation. She was the mother of three children who were proved to have the disease and of 2 more who are highly suspect. She had typical angiographic appearances of cardiomyopathy. These 3 patients all had a left ventricular end-diastolic pressure of 25-30 mmHg without an outflow gradient, indicating a high degree of resistance to inflow into the left ventricle.
Left ventricular end-diastolic pressure Left ventricular end-diastolic pressure measurements were available in 29 patients in group A, 20 in group B, and 9 in group C (Fig. 6) . The average resting pressure was considerably less in group A (I5-96 mmHg) than in either group B (20o4 + 8 mmHg) or in Group C (22-6 ± 8 mmHg). As could be predicted, it also bore some relation to symptom class. The average pressure for Class I patients was I4-6 ± 6 mmHg; for those with Class II symptoms, 17-5 ± 7 mmHg; and with Class III symptoms 27-I ± 6 mmHg. It was significantly higher in those patients with Class III disability (P = o0o04), but no significant difference occurred between Class I and Class II patients. It has been our repeated clinical observation, as previously stated, that in patients whose symptoms are increasing, clinical evidence of a raised pressure becomes more prominent throughout the course of the disease. none recorded was greater than 40 mmHg. It is probable that these gradients result from Bernheim effect and so represent yet another manifestation of massive septal hypertrophy (Bernheim, 1910 Further reviewing the histories of our other women patients, we found 7 additional patients in whom there was a close temporal relation between the initial diagnosis and the birth of the last child. In 7 patients, 15 pregnancies occurred, and in ii pregnancies in 6 patients, dyspnoea developed during pregnancy, which ranged in severity from Class II to Class III. All the pregnancies, save one, proceeded to term and resulted in a normal infant. The exception was a stillbirth with multiple congenital abnormalities.
Infective endocarditis Infective endocarditis occurred in 4 of our patients, 3 ofwhom have already been reported in detail (Vecht and Oakley, I968) . One patient was treated for 6 weeks for endocarditis with intravenous penicillin and was considered cured. He died as a result of a ruptured mycotic cerebral aneurysm, and at necropsy evidence of healed infective endocarditis was found on the mitral valve. The second patient died suddenly in another hospital after a short febrile illness. Blood cultures early in the disease grew pneumococci, and she had developed splinter haemorrhages shortly before death. Her death was quite sudden and did not follow a long period of steadily worsening symptoms. A necropsy was not performed. The third patient was treated successfully for Staphylococcus albus endocarditis.
It is probable that infective endocarditis may occur either on the mitral valve, when there is mitral regurgitation, or on the aortic valve in association with outflow tract obstruction. Therapy Medical (Table 7 ) Drugs such as digitalis and isoprenaline which have a positive inotropic effect on the myocardium are well known to increase the systolic pressure gradient in hypertrophic obstructive cardiomyopathy (Braunwald and Ebert, I962) . Experience in acute obstruction has shown betaadrenergic blockade to block these effects, but not to influence the resting gradient (Goodwin et al., I964; Flamm, Harrison, and Hancock, I968).
We have already reported the results of treatment of a small number of patients with this form of cardiomyopathy with long-term beta-adrenergic blockade (Cherian et al., I966) . This study has been expanded, and experience is now available on the treatment of 47 patients treated with propranolol. Initially, the dose of propranolol was 30 mg daily, but more recently larger doses of up to I20 mg daily have been used, and i i patients have been treated with up to go mg a day for 6 months or more. An additional io patients have been treated surgically in addition to receiving propranolol and will be included in the discussion of surgical therapy.
Of the 47 patients, 25 were male and 22 were female, their ages ranging from 3 to 55 years; the follow-up has now extended for three years. In evaluating the symptomatic results, we have noted any change in symptom class. Using these criteria, 28 (60%) patients reported no real change in their disability. Six (12%) deteriorated symptomatically and 9 (I9%) have shown improvement (Table 7) . Many patients reported symptomatic relief of a minor degree, dyspnoea becoming less in i6 Angina was reduced in the majority and palpitations in the minority.
Objective evidence of improvement was more difficult to evaluate and was lacking in most patients. There was some relation between symptomatic relief and the haemodynamic state. Angina was relieved more frequently in those patients with an outflow gradient of 50 mmHg or more, and with a left ventricular end-diastolic pressure of less than IS mmHg.
Four patients died while taking propranolol. One death was from an unrelated preexisting neurological condition in a woman who had been deteriorating. Three others were sudden deaths. One occurred in a familial patient, whose brother had died suddenly in his twenties and who was shown to have hypertrophic obstructive cardiomyopathy at necropsy. The other two were sporadic patients. One further patient had discontinued propranolol 5 months before his death, previously having taken the drug for one year. All 4 of these patients had been taking the drug for less than i8 months.
Surgical Our initial experience in the surgical treatment has already been reported (Bentall et al., I965) . To the original I2 patients, io have been added. Sixteen have survived the operation. There were 6 immediate deaths, 3 from complete heart block.
Three late deaths have occurred -one, 2 years after operation from a ruptured mycotic cerebral aneurysm secondary to infective endocarditis, one from atrial fibrillation, systemic embolism, and pulmonary oedema, and one suddenly, presumably from arrhythmia.
The criteria for recommending a patient for operation were the presence of significant symptoms, an outflow gradient of at least 50 mmHg, and the angiographic demonstration of a definite obstruction to left ventricular outflow. More recently, the indication for operation has been the failure of such a patient to respond to propranolol therapy.
All the surgical patients had originally presented with at least Class II or III disability, and all had experienced some deterioration before their being recommended for operation. Fourteen of the surviving patients have improved at least one symptomatic class. One patient is unchanged and another has continued to deteriorate despite operation and propranolol.
Both pre-and postoperative haemodynamic data are available for comparison in I2 of the surviving cases. The average preoperative gradient was 8I + 35 mmHg. The average 4 highest resting gradient after operation was 34 ± i8 mmHg. The gradient fell in all except 2 after operation. One of the patients in whom there was no postoperative change had a gradient of 8o mm before and go mm after operation. The other patient showed an increase of 60 mmHg over the preoperative gradient, and in this patient there has been steady deterioration.
Postoperatively, cineangiocardiography has shown very little change from the preoperative appearance. In S patients, mitral regurgitation present before had improved or disappeared after operation. These results are less impressive than those of Morrow et al. (i968).
It has become our policy to continue propranolol after operation in the surgical patients.
Discussion
Our experience has been similar to that of others (Frank and Braunwald, I968; Maurice et al., I966) with respect to the age of the patients and the severity of symptoms.
Progress Patients who remained asymptomatic were significantly younger at the time of detection than those with symptoms, suggesting that the disease commonly had a prolonged asymptomatic period between the development of clinical stigmata of the disease and the development of disability. Detection of the heart murmur may have brought to light symptoms real or imagined in patients who might otherwise have remained undiscovered until they presented at an older age with greater disability. The group C patients can now be seen to represent patients whose murmurs had not been detected during the long latent period before disability became gradually noticeable to them.
During the course of follow-up, we have noted, as have others (Wigle, I964) , a fluctuation in the signs and symptoms from visit to visit, but we have tried to analyse the patients in terms of a general trend. In the symptomatic patients in groups A, B, and C, there was no significant relation between the initial signs and the prognosis. Treatment Because of the lack of previous information concerning the untreated natural history of large numbers of patients with hypertrophic obstructive cardiomyopathy, it is hard to assess our results with medical therapy propranolol. The objective results of the long-term use of the drug are somewhat unimpressive, though the trend is encouraging. Its use has been associated with a lack of progression of or development of symptoms in most cases. There has been substantial improvement in a few. The most important indication for its use would be the demonstration of the prevention of sudden death. In addition, the relief of angina and diminution of arrhythmia are important factors. The effect of beta-adrenergic blockade on ventricular function is under study, and preliminary work suggests that it can reduce cardiac work and lower left ventricular diastolic pressure on effort (Edwards et al., 1970; Goodwin, I970;  Webb-Peploe et al., I97I).
Surgery may continue to play a role in the treatment of some patients despite the use of propranolol. Lowering the ventricular outflow tract and symptomatic improvement in surviving cases has been the experience of most groups (Bigelow et al., I966; Morrow et al., I968) .
A unifying concept Our observations on the natural history of the disease appear to support the following unifying concept.
The initiating mechanism remains obscure. The presence ofmitral insufficiency and papillary muscle hypertrophy in a large percentage of the cases has led us to believe that abnormal papillary muscle function is an important factor in the development of hypertrophic obstructive cardiomyopathy (Oakley et al., I967; Goodwin, I967) . Abnormal contraction of the papillary muscles could result in their abnormal apposition to the hypertrophied septum, initiating or intensifying outflow obstruction. This might be followed by a vicious circle of more hypertrophy, further regurgitation, and further obstruction (Goodwin, 1970) . Robb and Robb (I942) pointed out that if the deep bulbospiral muscle of the left ventricle contracted prematurely, it would cause aortic outflow obstruction by a mechanism of septal hypertrophy.
Some mechanism, perhaps abnormal growth of muscle, initially causes a disorder of myocardial contraction, characterized by the rapidity and completeness of ventricular emptying. Initially, the disease is asymptomatic or only mildly symptomatic, and tends to run a stable course. It is characterized by septal hypertrophy, outflow obstruction, and mitral regurgitation. At this point, there is usually already some increase in end-diastolic pressure. Symptoms when they develop are due to high left atrial pressure (dyspnoea) and to increased cardiac work and myocardial oxygen demands (angina).
The condition may seem to remain static or worsen depending on the segment of the natural history which is observed. Inflow resistance tends to increase, and is due to massive hypertrophy and varying degrees of replacement fibrosis. Outflow obstruction may disappear and in some patients may never have been present (Oakley, I97ib; Goodwin, I970) .
It is possible that the cause of the disease may be modified at this point by betaadrenergic blockade, and in some patients by operation. As yet there is no proof that either method of treatment will certainly prevent progression, however. Important inflow resistance is manifested by diminution of the sys- 
